BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4030715)

  • 1. Difference in enzymatic properties between alpha-thrombin-staphylocoagulase complex and free alpha-thrombin.
    Kawabata S; Morita T; Iwanaga S; Igarashi H
    J Biochem; 1985 Apr; 97(4):1073-8. PubMed ID: 4030715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Difference in enzymatic properties between "staphylothrombin" and free alpha-thrombin.
    Kawabata S; Morita T; Miyata T; Kaida S; Igarashi H; Iwanaga S
    Ann N Y Acad Sci; 1986; 485():27-40. PubMed ID: 3551730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-thrombin-catalyzed hydrolysis of fibrin I. Alternative binding modes and the accessibility of the active site in fibrin I-bound alpha-thrombin.
    Naski MC; Shafer JA
    J Biol Chem; 1990 Jan; 265(3):1401-7. PubMed ID: 2295636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The action of thrombin on peptide p-nitroanilide substrates: hydrolysis of Tos-Gly-Pro-Arg-pNA and D-Phe-Pip-Arg-pNA by human alpha and gamma and bovine alpha and beta-thrombins.
    Lottenberg R; Hall JA; Fenton JW; Jackson CM
    Thromb Res; 1982 Nov; 28(3):313-32. PubMed ID: 7179220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombin specificity with tripeptide chromogenic substrates: comparison of human and bovine thrombins with and without fibrinogen clotting activities.
    Sonder SA; Fenton JW
    Clin Chem; 1986 Jun; 32(6):934-7. PubMed ID: 3708816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of fragments of hirudin to investigate thrombin-hirudin interaction.
    Dennis S; Wallace A; Hofsteenge J; Stone SR
    Eur J Biochem; 1990 Feb; 188(1):61-6. PubMed ID: 2180697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the catalytic defect in the dysthrombin, Thrombin Quick.
    Henriksen RA; Owen WG
    J Biol Chem; 1987 Apr; 262(10):4664-9. PubMed ID: 3558361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzymatic properties of staphylothrombin, an active molecular complex formed between staphylocoagulase and human prothrombin.
    Kawabata S; Morita T; Iwanaga S; Igarashi H
    J Biochem; 1985 Dec; 98(6):1603-14. PubMed ID: 4093448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient kinetics of heparin-catalyzed protease inactivation by antithrombin III. Linkage of protease-inhibitor-heparin interactions in the reaction with thrombin.
    Olson ST
    J Biol Chem; 1988 Feb; 263(4):1698-708. PubMed ID: 3338989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human alpha- and gamma-thrombin specificity with tripeptide p-nitroanalide substrates under physiologically relevant conditions.
    Witting JI; Miller TM; Fenton JW
    Thromb Res; 1987 May; 46(4):567-74. PubMed ID: 3617013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the thrombin insertion loop 144-155. Study of thrombin mutations W148G, K154E and a thrombin-based synthetic peptide.
    Bouton MC; Plantier JL; Dembak M; Guillin MC; Rabiet MJ; Jandrot-Perrus M
    Eur J Biochem; 1995 Apr; 229(2):526-32. PubMed ID: 7744076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of a pro-enzyme by a stoichiometric reaction with another protein. The reaction between prothrombin and staphylocoagulase.
    Hemker HC; Bas BM; Muller AD
    Biochim Biophys Acta; 1975 Jan; 379(1):180-8. PubMed ID: 1115793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombin properties of C-terminus of hirudin using synthetic unsulfated N alpha-acetyl-hirudin45-65.
    Krstenansky JL; Mao SJ
    FEBS Lett; 1987 Jan; 211(1):10-6. PubMed ID: 3803584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosteric changes of thrombin catalytic site induced by interaction of bothrojaracin with anion-binding exosites I and II.
    Monteiro RQ; Rapôso JG; Wisner A; Guimarães JA; Bon C; Zingali RB
    Biochem Biophys Res Commun; 1999 Sep; 262(3):819-22. PubMed ID: 10471408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin inhibition by hirudin: how hirudin inhibits thrombin.
    Fenton JW; Villanueva GB; Ofosu FA; Maraganore JM
    Haemostasis; 1991; 21 Suppl 1():27-31. PubMed ID: 1894193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of protons on the thrombin-fibrinogen interaction.
    Picozzi M; Landolfi R; De Cristofaro R
    Eur J Biochem; 1994 Feb; 219(3):1013-21. PubMed ID: 8112314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staphylocoagulase-binding region in human prothrombin.
    Kawabata S; Morita T; Iwanaga S; Igarashi H
    J Biochem; 1985 Jan; 97(1):325-31. PubMed ID: 3846593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton inventory studies of alpha-thrombin-catalyzed reactions of substrates with selected P and P' sites.
    Enyedy EJ; Kovach IM
    J Am Chem Soc; 2004 May; 126(19):6017-24. PubMed ID: 15137766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The linkage between binding of the C-terminal domain of hirudin and amidase activity in human alpha-thrombin.
    de Cristofaro R; Rocca B; Bizzi B; Landolfi R
    Biochem J; 1993 Jan; 289 ( Pt 2)(Pt 2):475-80. PubMed ID: 8424791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin-specific inhibition by and slow cleavage of hirulog-1.
    Witting JI; Bourdon P; Brezniak DV; Maraganore JM; Fenton JW
    Biochem J; 1992 May; 283 ( Pt 3)(Pt 3):737-43. PubMed ID: 1290488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.